Neil McFarlane is President, Chief Executive Officer and Director of ZEVRA THERAPEUTICS, INC. (ZVRA). The company reported total compensation of $3,782,042 for fiscal year 2025.
| Salary | $729,167 |
|---|---|
| Bonus | $0 |
| Stock awards | $874,125 |
| Option awards | $1,748,250 |
| Non-equity incentive plan | $418,950 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $11,550 |
| Total | $3,782,042 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure ZEVRA THERAPEUTICS, INC. filed April 20, 2026, accession 0001434647-26-000025.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| R. LaDuane Clifton | Former Chief Financial Officer and Treasurer | $3,821,924 |
| Neil McFarlane this page | President, Chief Executive Officer and Director | $3,782,042 |
| Rahsaan Thompson | Chief Legal Officer, Secretary and Compliance Officer | $1,571,374 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full ZEVRA THERAPEUTICS, INC. compensation brief.
Neil McFarlane's compensation sits inside ZEVRA THERAPEUTICS, INC.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.